Intravenous magnesium for complex regional pain syndrome type 1 (CRPS 1) patients: A pilot study

Pain Medicine

Volumn 10, Issue 5, 2009, Pages 930-940

  Collins, Susan ^a,b   Zuurmond, Wouter W A ^a,b   de Lange, Jaap J ^a   van Hilten, Bob J ^b,c   Perez, Roberto S G M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Knowledge Consortium Trauma Related Neuronal Dysfunction   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CRPS; Magnesium; NMDA antagonists

Indexed keywords

DICLOFENAC; IBUPROFEN; MAGNESIUM SULFATE; NAPROXEN; PARACETAMOL; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; EYE BURNING; FATIGUE; FEMALE; FLUSHING; FUNCTIONAL ASSESSMENT; HEADACHE; HEART PALPITATION; HUMAN; HYPERALGESIA; HYPERESTHESIA; HYPESTHESIA; HYPOALGESIA; INJECTION PAIN; MAGNESIUM BLOOD LEVEL; MALE; MCGILL PAIN QUESTIONNAIRE; NAUSEA; PAIN ASSESSMENT; PAIN PARAMETERS; PHYSIOTHERAPY; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; SKIN SENSITIVITY; TREATMENT RESPONSE; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; REFLEX SYMPATHETIC DYSTROPHY; YOUNG ADULT;

EID: 68349131607     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00639.x     Document Type: Article

References (41)

1. Marinus J, Van Hilten JJ. Clinical expression profiles of complex regional pain syndrome, fibromyalgia and a-specific repetitive strain injury: More common denominators than pain? Disabil Rehabil 2006;28:351-62.
2. Perez RSGM, Collins S, Marinus J, Zuurmond WWA, de Lange JJ. Diagnostic criteria for CRPS I: Differences between patient profiles using three different diagnostic sets. European Journal of Pain 2007;11:895-902.
3. Veldman PHJM, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy - Prospective-Study of 829 patients. Lancet 1993;342:1012-6.
4. Huygen FJPM, de Bruijn AGJ, de Bruin MT, et al. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002;11:47-51.
5. Weber M, Birklein F, Neundorfer B, et al. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001;91:251-7.
6. Oyen WJG, Arntz IE, Claessens RAMJ, et al. Reflex sympathetic dystrophy of the hand: An excessive inflammatory response? Pain 1993;55:151-7.
7. van der Laan L, Goris RJA. Reflex sympathetic dystrophy - An exaggerated regional inflammatory response? Hand Clin 1997;13:373.
8. Perez RSGM, Zuurmond WWA, Bezemer PD, et al. The treatment of complex regional painsyndrome type I with free radical scavengers: A randomized controlled study. Pain 2003;102:297-307.
9. Zuurmond WWA, Langendijk PNJ, Bezemer PD, et al. Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream. Acta Anaesthesiol Scand 1996;40:364-7.
10. Lee CJ, Bardoni R, Tong CK, et al. Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release. Neuron 2002;35:135-46.
11. Bennett GJ. Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA-receptor. J Pain Symptom Manage 2000;19:S2-6.
12. Petrenko AB, Yamakura T, Baba H, et al. The Role of N-Methyl-D-Aspartate (NMDA) receptors in pain: A review. Anesth Analg 2003;97:1108-16.
13. Carlton SM, Coggeshall RE. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 1999;820:63-70.
14. Farajidavar A, Gharibzadeh S, Towhidkhah F, et al. A cybernetic view on wind-up. Med Hypotheses 2006;67:304-6.
15. Schwartzman RJ, Alexander GM, Grothusen J. Pathophysiology of complex regional pain syndrome. Expert Rev Neurother 2006;6:669-81.
16. Liu HT, Hollmann MW, Liu WH, et al. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 2001;92:1173-81.
17. Levaux C, Bonhomme V, Dewandre PY, et al. Effect of intra-operative magnesium sulphate on pain relief and patient comfort after major lumbar orthopaedic surgery. Anaesthesia 2003;58:131-5.
18. Tramer MR, Schneider J, Marti RA, et al. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996;84:340-7.
19. Mikkelsen S, Dirks J, Fabricius P, et al. Effect of intravenous magnesium on pain and secondary hyperalgesia associated with the heat/ capsaicin sensitization model in healthy volunteers. Br J Anaesth 2001;86:871-3.
20. Brill S, Sedgwick PM, Hamann W, et al. Efficacy of intravenous magnesium in neuropathic pain. Br J Anaesth 2002;89:711-4.
21. Tanaka M, Shimizu S, Nishimura W, et al. Relief of neuropathic pain with intravenous magnesium. Masui 1998;47:1109-13.
22. Crosby V, Wilcock A, Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage 2000;19:35-9.
23. Stanton-Hicks M, Janig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: Changing concepts and taxonomy. Pain 1995;63:127-33.
24. World Health Organization. WHO Guidelines: Cancer Pain Relief. Geneva: World Health Organization; 1996.
25. Oerlemans HM, Oostendorp RAB, de Boo T, et al. Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I. Arch Phys Med Rehabil 2000;81:49-56.
26. van der Kloot WA, Oostendorp RA, van der MJ, et al. [The Dutch version of the McGill pain questionnaire: A reliable pain questionnaire]. Ned Tijdschr Geneeskd 1995;139:669-73.
27. Rommel O, Malin JP, Zenz M, et al. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain 2001;93:279-93.
28. Oerlemans HM, Goris RJA, Oostendorp RAB. Impairment level sumscore in reflex sympathetic dystrophy of one upper extremity. Arch Phys Med Rehabil 1998;79:979-90.
29. Perez RSGM, Oerlemans HM, Zuurmond WWA, et al. Impairment level SumScore for lower extremity Complex Regional Pain syndrome type I. Disabil Rehabil 2003;25:984-91.
30. Oerlemans HM, Perez RSGM, Oostendorp RAB, et al. Objective and subjective assessments of temperature differences between the hands in reflex sympathetic dystrophy. Clin Rehabil 1999;13:430-8.
31. Oerlemans HM, Cup EHC, de Boo T, et al. The Radboud skills questionnaire: Construction and reliability in patients with reflex sympathetic dystrophy of one upper extremity. Disabil Rehabil 2000;22:233-45.
32. Roorda LD, Roebroeck ME, van Tilburg T, et al. Measuring activity limitations in walking: Development of a hierarchical scale for patients with lower-extremity disorders who live at home. Arch Phys Med Rehabil 2005;86:2277-83.
33. Kemler MA, De Vet HCW. Health-related quality of life in chronic refractory reflex sympathetic dystrophy (complex regional pain syndrome type I). J Pain Symptom Manage 2000;20:68-76.
34. EuroQol-A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
35. Fontaine N, Rosengren B. Directive 2001/20/EC of the European parliament and the council. Official Journal of the European Communities 2001;L121/ 34-L121/44.
36. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-9.
37. Oerlemans HR, Oostendorp RAB, de Boo T, et al. Pain and reduced mobility in complex regional pain syndrome I: Outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain 1999;83:77-83.
38. Haghighi L. Prevention of preterm delivery: Nifedipine or magnesium sulfate. Int J Gynecol Obstet 1999;66:297-8.
39. Zygmunt M, Heilmann L, Berg C, et al. Local and systemic tolerability of magnesium sulphate for tocolysis. Eur J Obstet Gynecol Reprod Biol 2003;107:168-75.
40. Altman DG. Practical Statistics for Medical Research. London: Champman and Hall; 1991.
41. Birklein F, Riedl B, Sieweke N, et al. Neurological findings in complex regional pain syndromes - Analysis of 145 cases. Acta Neurol Scand 2000;101:262-9.